Navigation Links
Evidence for omega 3 fats less conclusive than we thought, say experts

A study published online by the BMJ today doesn't find evidence of a clear benefit of omega 3 fats on health.

These findings do not rule out an important effect of omega 3 fats, but suggest that the evidence should be reviewed regularly, say the researchers.

Consumption of long chain omega 3 fatty acids, found in oily fish and fish oils, and a shorter chain omega 3, found in some plant oils, is thought to protect against heart disease. UK guidelines encourage the general public to eat more oily fish, and higher amounts are advised after a heart attack.

Researchers analysed 89 studies (48 randomised controlled trials and 41 cohort studies) to assess the health effects of long and short chain omega 3 fats on total mortality, cardiovascular events, cancer, and strokes.

Each study involved a treatment group and a control group and investigated the effect of omega 3 intake on health for at least six months. Differences in study quality were taken into account to identify and minimise bias.

Pooling the results showed no strong evidence that omega 3 fats have an effect on total mortality or combined cardiovascular events. The few studies at low risk of bias were more consistent, but they also showed no effect of omega 3 on total mortality or cardiovascular events.

When data on long chain omega 3 fats were analysed separately, total mortality and cardiovascular events were not reduced. No study showed increased risk of cancer or stroke with higher intake of omega 3, but there were too few events to rule out important effects.

Other recent reviews of omega 3 trials found that omega 3 fats decrease mortality, but the publication of a large contradictory trial has changed the overall picture. The authors cannot say exactly why the results of this trial differ from the other large studies in this field.

They therefore conclude that it is not clear whether long chain or short chain omega 3 fats (together or separat ely) reduce or increase total mortality, cardiovascular events, cancer, or strokes.

UK guidelines advising people to eat more oily fish should continue at present but the evidence should be reviewed regularly, say the authors. However, it is probably not appropriate to recommend a high intake of omega 3 fats for people who have angina but have not had a heart attack.

To understand the effects of omega 3 fats on health, we need more high quality randomised controlled trials of long duration that also report the associated harms, they conclude.

We are faced with a paradox, says Eric Brunner in an accompanying editorial. Health recommendations advise increased consumption of oily fish and fish oils. However, industrial fishing has depleted the world's fish stocks by some 90% since 1950, and rising fish prices reduce affordability particularly for people with low incomes.

Global production trends suggest that, although fish farming is expanding rapidly, we probably do not have a sustainable supply of long chain omega 3 fats, he warns.


'"/>

Source:BMJ-British Medical Journal


Related biology news :

1. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
2. Researchers create pigs that produce heart-healthy omega-3 fatty acids
3. Innovative method for creating a human cytomegalovirus vaccine outlined
4. LIAI scientists make important finding on cytomegalovirus transmission
5. DNA conclusive yet still controversial, Carnegie Mellon professor says
6. Oceans more vulnerable to agricultural runoff than previously thought, study finds
7. Katrina floodwaters not as toxic to humans as previously thought, study says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: